Johnson & JohnsonJNJ:NYSE RT Quote|Last NYSE Arca, VOL From CTA|USD After Hours:Last |6:40 AM EDT 157.20+0.28(+0.18%) Volume 3,826 Close 156.92-0.55(-0.35%) Volume 5,837,434 52 week range 140.68-169.99 SummaryNewsProfileEarningsPeersFinancialsOptionsOwnership ...
healthcare consumer utilities financials industrials stock comparison tools faang stocks gold etfs cash equivalents big bank stocks big pharma stocks retail stocks top indexes dow jones s&p 500 nasdaq gold bitcoin market outlook...
Trending Stocks Trending ETFs Trending Indexes Data as of Apr 30, 2025 COMP Nasdaq Composite Index 17,446.34 -14.98-0.09% NDX Nasdaq-100 19,571.02 +26.07+0.13% NQUS500LC Nasdaq Us 500 Large Cap 2,906.34 +3.72+0.13% Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at...
End of interactive chart. Stock Analysis Stock Ideas Long Ideas Stock Upgrades & Downgrades Editors' Picks Quick Picks & Lists Emerging Markets Stock Screener Stocks by Quant Top Stocks Top Quant Dividend Stocks High Dividend Yield Stocks Top Dividend Stocks...
Stocks:Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements. Fundamental company data and analyst estimates provide...
Johnson & Johnson stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
boasts a PEG ratio of 2.65. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. Large Cap Pharmaceuticals stocks are, on average, holding a PEG ratio of 1.47 based on yesterday's closing prices. ...
Access Stocks, ETF’s, Mutual Funds, Futures, Commodities, Forex and Cryptos - you can download daily data back to the inception of our database, or 1-minute data going back 10-years. Intraday data is available, down to 1-minute increments, approximately 10 years prior to today’s date...
Johnson & Johnson (JNJ:DUS) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.
Net-net, the operating backdrop for Johnson & Johnson has not been favorable over the past 18 months. As such, Johnson & Johnson stock has dropped during that stretch, while most other stocks have rallied. Will this under-performance persist? I think so, at least for the foreseeable future...